Searched for
REGULATORY REVIEW CELL
Fast-tracked power plants fuel AI boom, with little public scrutinyNew power plants are being built at an unprecedented speed to meet the growing demand of tech companies. These facilities, often fueled by ...- Rajesh Exports founder denies fund diversion in ACC Energy, says SEBI misread accounting entriesRajesh Exports Chairman Rajesh Mehta refutes SEBI's fund diversion claims. He states accounting entries were misunderstood. The company fac...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Apple flags handset modification hurdles for satellite D2D rollout in IndiaApple advises against hardware changes for direct-to-device satellite links in India. The company prioritizes current mobile networks. Othe...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- New Mexico seeks $3.7 billion, changes to Meta platforms in youth harm trialNew Mexico is suing Meta Platforms, accusing it of harming young users. The state wants a judge to declare Meta's Facebook, Instagram, and ...
- Inox Clean Energy eyes $750M Boviet Solar buy to enter US marketIndian renewable energy firm Inox Clean Energy plans to acquire US-based Boviet Solar. This strategic move aims to expand Inox's footprint ...
- Aurobindo Pharma’s Dyrupeg faces Health Canada compliance noticeCuraTeQ Biologics, a part of Aurobindo Pharma, has secured a crucial approval from Health Canada for its biosimilar drug Dyrupeg. This medi...
- Biocon chief bats for dual-agency model to fast-track drug approvalsBiocon's Kiran Mazumdar-Shaw suggests a new drug approval system. The Indian Council of Medical Research would handle scientific reviews fo...
- RBI’s cell on regulations, advisory group to help systematic, timely review of rulesThe Reserve Bank of India has established a Regulatory Review Cell (RRC) within its Department of Regulation to streamline regulatory chang...
- RBI forms committee for periodic review of regulationsThe Reserve Bank of India (RBI) is establishing a Regulatory Review Cell (RRC) by October 1, 2025, to systematically review its regulations...
- MahaRERA sees compliance surge, project updates jump from 0.02% to 62%MahaRERA has seen a sharp rise in compliance among real estate developers, with over 62% of projects now updating details through the Quart...
- 11 countries already recognise Indian pharmacopoeia as their standard: DCGI Rajeev RaghuvanshiIndia is supplying drugs, vaccines, and medical devices to over 200 countries, with 11 countries recognizing Indian pharmacopoeia standards...
- Aurigene reports promising phase-1 data for its CAR-T therapy against myelomaAurigene Oncology has announced promising phase-1 results for its novel CAR-T cell therapy, Ribrecabtagene autoleucel, in patients with mul...
- Only 195 projects set up grievance redressal cell despite MahaRERA directiveOnly 195 projects in Maharashtra have complied with the directive to establish a complaint redressal cell by the Maharashtra Real Estate Re...
- Govt to re-work UPA's drug regulatory billThe regulatory framework for ensuring quality, safety and efficacy of medical products including medicines, devices was provided for in the...
- Indosolar reports Q2 loss at Rs 48 croreThe company had posted a standalone loss of Rs 37.19 crore in the corresponding quarter last fiscal, the company said in a regulatory filin...
- Make in India: How PM Modi's ambitious plan will make India a manufacturing superpowerPM Narendra Modi launched ‘Make in India' on September 25, 2014. The ambitious initiative seeks to make India a manufacturing superpower.
- Biotech regulator needs engineeringIt is good news that the government is expediting the process of setting up the national biotechnology regulatory authority, which is envis...
Load More
